Home » Topics » BioWorld Science

BioWorld Science
RSS

Zenith advances trial of ZEN-3694 in metastatic CRPC into phase II

June 5, 2018

PFK/FBPase 1 inhibitors identified at Merck KGaA

June 5, 2018

First-in-human results from Millennium's TAK-931 in advanced solid tumors

June 5, 2018

Dynavax Technologies presents Toll-like receptor 7/8/9 antagonists

June 5, 2018

GERD candidate X-842 safe and well tolerated in first-in-human study

June 5, 2018

Cyxone chooses to complete acquisition of rabeximod

June 5, 2018

Myalepta receives positive CHMP opinion for generalized and partial lipodystrophy

June 5, 2018

Prelude Therapeutics identifies PRMT5 inhibitors

June 5, 2018

MALT1-targeting compounds synthesized by the Dana-Farber Cancer Institute and collaborators

June 5, 2018

Hepagene Therapeutics describes farnesoid X receptor agonists

June 5, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 27, 2026.
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 24, 2026
SERCA inhibitor shows promise for MSA-C treatment
BioWorld Science
At the ongoing International Conference on Alzheimer’s and Parkinson’s Diseases and Related Neurological Disorders (AD/PD 2026) in Copenhagen, researchers...